ESG is everyone's business at Teva

Environmental, Social and Governance Progress Report

   

As a company focused on improving the lives of patients, environmental, social and governance (ESG) has always been central to Teva.

In 2021, we advanced our ESG efforts and strengthened the connection between ESG and our business—holding ourselves accountable to future progress. Read more in our 2021 ESG Progress Report.

 

 
Teva’s 2021 ESG Progress Report
 

ESG Report Disclosures
Kåre-Schultz- Chief-Executive-Officer-Teva-Pharmaceutical-Industries-Official-Portrait

“As one of the world's largest manufacturers of generic medicines, ESG is integral to the long-term strategy of our company and is part of everything we do. We are in a unique position to help create a healthier future, bringing our essential medicines within reach for more people and reinforcing business integrity through our compliance and ethics policies and trainings.” - Kåre Schultz, Teva President & CEO

Making Connections for the Health of People and Our World

Our ESG strategy drives us to be responsible in all we do—recognizing the connection between our actions and our impact. Take a look at how this came to life in 2021.

Discover more Making Connections for the Health of People and Our World

Action & Accountability: Highlights of Teva’s ESG Progress

In 2021, we advanced our ESG efforts and strengthened the connection between ESG and our business

Discover more

Teva Publishes 2021 Environmental, Social and Governance Progress Report

Discover more
Previous Reports